抗体薬物複合体市場は、2023年の81億米ドルから2031年までに380億7000万米ドルに達すると予想されています。市場は、2023年から2031年にかけて21.3%のCAGRで成長すると推定されています。市場の成長を促進する主な要因には、主要企業による戦略的投資と承認済み製品の入手可能性の増加が含まれます。さらに、新しい適応症への拡大により、予測期間中に市場が押し上げられる可能性があります。ただし、製造上の課題が市場の阻害要因となっています。
抗体薬物複合体市場の主要企業間の合併、買収、パートナーシップ、協力などの戦略的投資は、その成長と発展に大きな影響を与えます。これらの戦略により、企業はリソースをプールし、専門知識を共有し、補完的な強みを活用して、急速に進化する状況において競争力を高めることができます。革新的ながん治療法が模索される中、抗体薬物複合体は、健康な組織を温存しながらがん細胞を選択的に標的にして破壊し、それによって副作用を最小限に抑える能力で注目を集めています。その結果、大手製薬会社やバイオテクノロジー企業は、抗体薬物複合体の開発と商業化を加速するために戦略的提携に取り組むことが増えています。
市場の競争が激化するにつれ、企業は有望な抗体薬物複合体技術や候補をパイプラインに持つ他の企業を買収または合併しようとしています。たとえば、大手製薬会社は、先進技術を既存の製品ラインに迅速に組み込むために、抗体と薬物の複合体の開発を専門とする小規模なバイオテクノロジー企業を買収します。このような買収は、買収企業がポートフォリオを強化し、治療薬の有効性と安全性プロファイルを改善できる新しいリンカー技術、ペイロード、標的メカニズムにアクセスできるようにするのに役立ちます。2024 年 10 月、GlycoMimetics, Inc.は、固形腫瘍の治療を目的とした腫瘍治療薬のパイプラインを推進する非公開バイオテクノロジー企業Crescent Biopharma, Inc.と買収契約を締結しました。取引完了後、同社はCrescent Biopharma, Inc.の社名で運営される予定です。2024年3月、Johnson & Johnsonは、独自の合成生物学技術プラットフォームを備えた臨床段階のバイオ医薬品会社であるAmbrx Biopharma, Inc.を買収し、次世代の抗体薬物複合体を開発します。2024年9月、次世代の抗体薬物複合体の開発に携わるスイスの腫瘍学およびバイオテクノロジー企業であるAraris Biotech AGは、Innate Pharmaとの契約締結を発表しました。この契約に基づき、InnateはArarisにトランスグルタミナーゼ結合技術に関連する特許ポートフォリオを譲渡することになります。
抗体薬物複合体市場の競争環境は、戦略的投資に取り組む主要企業による高レベルの活動によって特徴付けられます。このダイナミズムは、企業が自社製品を差別化して市場でのリーダーシップを確立しようと努める際に、イノベーションと改善を促進します。腫瘍学への資本投資の流入が新規参入者を引きつけ、革新的なアイデアを促進するより活気のあるエコシステムにつながります。合併、買収、パートナーシップ、コラボレーションを通じた戦略的投資は、抗体薬物複合体市場の成長を促進する上で極めて重要な役割を果たします。これらの投資は、製品ポートフォリオの強化、製造プロセスの改善、効果的で標的を絞ったがん治療法の開発を推進するイノベーションの促進によって相乗効果のある環境を生み出します。
企業比較分析では、製品ポートフォリオ（製品の満足度、製品の特徴、入手可能性）、最近の市場の展開（合併と買収、新製品の発売と強化、投資と資金調達、受賞、契約、コラボレーション&パートナーシップ、認識、拡大）、および競争環境のより良い意思決定と理解を助ける地理的存在に基づいて抗体薬物複合体市場を評価および分類します。このレポートは、世界の抗体薬物複合体市場における主要ベンダーによる最近の重要な開発と革新を深く調査しています。主要な市場プレーヤーは、ADC Therapeutics SA、Pfizer Inc、F. Hoffmann-La Roche Ltd、第一三共株式会社（Daiichi Sankyo Co Ltd）、GSK Plc、Gilead Sciences Inc、AstraZeneca Plc、Astellas Pharma Inc、RemeGen Co Ltd、武田薬品工業株式会社（Takeda Pharmaceutical Co Ltd）、Merck KGaA、Johnson & Johnson、Bristol-Myers Squibb Co、BioNTech SE、AbbVie Inc.です。
技術に基づいて、抗体薬物複合体市場は開裂性リンカーと非開裂性リンカーに分類されます。2023年には、開裂性リンカーセグメントが市場で最大のシェアを占めました。用途に基づいて、抗体薬物複合体市場は血液がん、脳がん、乳がん、卵巣がん、肺がんなどに分類されます。2023 年には、乳がんセグメントが市場で最大のシェアを獲得しました。
抗体薬物複合体市場で事業を展開する企業は、さまざまな有機および無機戦略を採用しています。有機戦略には主に製品の発売と製品の承認が含まれます。市場で見られる無機的な成長戦略は、買収、コラボレーション、パートナーシップです。これらの成長戦略により、市場プレーヤーは事業を拡大し、地理的な存在感を高めることができるとともに、市場全体の成長に貢献することができます。さらに、買収やパートナーシップなどの戦略により、顧客ベースが強化され、製品ポートフォリオが拡大しました。抗体薬物複合体市場における主要企業による重要な開発を以下に示します。
2024年11月、AstraZenecはシンガポールに15億米ドルをかけて抗体薬物複合体（ADC）専用の製造施設を建設し、これにより同社のADCポートフォリオの世界供給が向上することになります。ADC は、標的抗体を使用して強力な抗がん剤をがん細胞に直接送達するように設計された高度な治療法です。
目次
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Antibody Drug Conjugates Market Landscape
4.1 PEST Analysis
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
4.2.2 List of Approved Products
4.2.3 Pipeline Analysis
4.2.4 Regulatory Guidelines
5. Antibody Drug Conjugates Market - Key Market Dynamics
5.1 Antibody Drug Conjugates Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Strategic Investments by Key Players
5.2.2 Increase in Availability of Approved Products
5.3 Market Restraints
5.3.1 Manufacturing Challenges
5.4 Market Opportunities
5.4.1 Expansion into New Indications
5.5 Future Trends
5.5.1 Expanding Clinical Trial Pipeline
5.6 Impact of Drivers and Restraints:
6. Antibody Drug Conjugates Market - Global Market Analysis
6.1 Antibody Drug Conjugates Market Revenue (US$ Million), 2021-2031
6.2 Overview
6.3 Antibody Drug Conjugates Market Forecast Analysis
7. Antibody Drug Conjugates Market Analysis - by Technology
7.1 Cleavable Linker
7.1.1 Overview
7.1.2 Cleavable Linker: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Non-cleavable Linker
7.2.1 Overview
7.2.2 Non-cleavable Linker: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8. Antibody Drug Conjugates Market Analysis - by Application
8.1 Blood Cancer
8.1.1 Overview
8.1.2 Blood Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Brain Cancer
8.2.1 Overview
8.2.2 Brain Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Ovarian Cancer
8.4.1 Overview
8.4.2 Ovarian Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Lung Cancer
8.5.1 Overview
8.5.2 Lung Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
9. Antibody Drug Conjugates Market Analysis - by Target
9.1 HER2
9.1.1 Overview
9.1.2 HER2: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
9.2 CD22
9.2.1 Overview
9.2.2 CD22: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
9.3 CD30
9.3.1 Overview
9.3.2 CD30: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
10. Antibody Drug Conjugates Market Analysis - by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Overview
10.1.2 Retail Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11. Antibody Drug Conjugates Market - Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Antibody Drug Conjugates Market Overview
11.2.2 North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3 North America: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.3.1 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Technology
11.2.4 North America: Antibody Drug Conjugates Market Breakdown, by Application
11.2.4.1 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Application
11.2.5 North America: Antibody Drug Conjugates Market Breakdown, by Target
11.2.5.1 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Target
11.2.6 North America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.6.1 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.7 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.2.7.1 North America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.2.7.2 United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.2.7.2.1 United States: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.2.2 United States: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.2.3 United States: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.2.4 United States: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.7.3 Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.2.7.3.1 Canada: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.3.2 Canada: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.3.3 Canada: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.3.4 Canada: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.7.4 Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.2.7.4.1 Mexico: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.4.2 Mexico: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.4.3 Mexico: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.4.4 Mexico: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Antibody Drug Conjugates Market Overview
11.3.2 Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3 Europe: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.3.1 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Technology
11.3.4 Europe: Antibody Drug Conjugates Market Breakdown, by Application
11.3.4.1 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Application
11.3.5 Europe: Antibody Drug Conjugates Market Breakdown, by Target
11.3.5.1 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Target
11.3.6 Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.6.1 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Distribution Channel
11.3.7 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.3.7.1 Europe: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.3.7.2 United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.2.1 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.2.2 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.2.3 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.2.4 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.3 Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.3.1 Germany: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.3.2 Germany: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.3.3 Germany: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.3.4 Germany: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.4 France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.4.1 France: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.4.2 France: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.4.3 France: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.4.4 France: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.5 Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.5.1 Italy: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.5.2 Italy: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.5.3 Italy: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.5.4 Italy: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.6 Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.6.1 Spain: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.6.2 Spain: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.6.3 Spain: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.6.4 Spain: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.7 Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.7.2 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.7.3 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.7.4 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Antibody Drug Conjugates Market Overview
11.4.2 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.3.1 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Technology
11.4.4 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Application
11.4.4.1 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Application
11.4.5 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Target
11.4.5.1 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Target
11.4.6 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.6.1 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Distribution Channel
11.4.7 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.4.7.1 Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.4.7.2 China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.2.1 China: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.2.2 China: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.2.3 China: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.2.4 China: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.3 Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.3.1 Japan: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.3.2 Japan: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.3.3 Japan: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.3.4 Japan: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.4 India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.4.1 India: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.4.2 India: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.4.3 India: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.4.4 India: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.5 Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.5.1 Australia: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.5.2 Australia: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.5.3 Australia: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.5.4 Australia: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.6 South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.6.1 South Korea: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.6.2 South Korea: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.6.3 South Korea: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.6.4 South Korea: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.7 Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.7.2 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.7.3 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.7.4 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Antibody Drug Conjugates Market Overview
11.5.2 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.3.1 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Technology
11.5.4 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.4.1 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Application
11.5.5 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.5.1 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Target
11.5.6 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.6.1 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Distribution Channel
11.5.7 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.5.7.1 Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.5.7.2 South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.5.7.2.1 South Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.2.2 South Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.2.3 South Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.2.4 South Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.3 Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.5.7.3.1 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.3.2 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.3.3 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.3.4 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.4 United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.4.2 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.4.3 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.4.4 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.5 Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.5.2 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.5.3 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.5.4 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Antibody Drug Conjugates Market Overview
11.6.2 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.6.3 South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.3.1 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Technology
11.6.4 South and Central America: Antibody Drug Conjugates Market Breakdown, by Application
11.6.4.1 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Application
11.6.5 South and Central America: Antibody Drug Conjugates Market Breakdown, by Target
11.6.5.1 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Target
11.6.6 South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.6.1 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Distribution Channel
11.6.7 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.6.7.1 South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast Analysis - by Country
11.6.7.2 Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.6.7.2.1 Brazil: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.2.2 Brazil: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.2.3 Brazil: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.2.4 Brazil: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.7.3 Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.6.7.3.1 Argentina: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.3.2 Argentina: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.3.3 Argentina: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.3.4 Argentina: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.7.4 Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.4.2 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.4.3 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.4.4 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1.1 Heat Map Analysis
12.1.2 Company Share Analysis:
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Antibody Drug Conjugates Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 ADC Therapeutics SA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Daiichi Sankyo Co Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 SWOT Analysis
14.4.5 Key Developments
14.5 GSK Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 SWOT Analysis
14.5.5 Key Developments
14.6 Gilead Sciences Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca Plc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Astellas Pharma Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 RemeGen Co Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 SWOT Analysis
14.9.5 Key Developments
14.10 Takeda Pharmaceutical Co Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Merck KGaA
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Johnson & Johnson
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Bristol-Myers Squibb Co
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
14.14 BioNTech SE
14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments
14.15 AbbVie Inc
14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments
15. Appendix
15.1 About The Insight Partners
LIST OF TABLES
Table 1. Antibody Drug Conjugates Market Segmentation
Table 2. List of Vendors
Table 3. Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Table 4. Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
Table 5. Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 6. Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million) - by Target
Table 7. Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 8. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 9. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 11. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 12. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 13. United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 14. United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 16. United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 17. Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 18. Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 19. Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 20. Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 21. Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 22. Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 23. Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 24. Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 25. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 26. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 27. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 28. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 29. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 30. United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 31. United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 32. United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 33. United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 34. Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 35. Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 36. Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 37. Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 38. France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 39. France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 40. France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 41. France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 42. Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 43. Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 44. Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 45. Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 46. Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 47. Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 48. Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 49. Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 50. Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 51. Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 52. Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 53. Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 54. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 55. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 57. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 58. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 59. China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 60. China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 61. China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 62. China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 63. Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 64. Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 65. Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 66. Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 67. India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 68. India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 69. India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 70. India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 71. Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 72. Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 73. Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 74. Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 75. South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 76. South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 77. South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 78. South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 79. Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 80. Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 81. Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 82. Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 83. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 84. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 85. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 86. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 87. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 88. South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 89. South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 90. South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 91. South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 92. Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 93. Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 94. Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 95. Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 96. United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 97. United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 98. United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 99. United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 100. Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 101. Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 102. Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 103. Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 104. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 105. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 106. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 107. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 108. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 109. Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 110. Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 111. Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 112. Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 113. Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 114. Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 115. Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 116. Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 117. Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Technology
Table 118. Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 119. Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Target
Table 120. Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 121. Company Share Analysis
Table 122. Recent Organic Growth Strategies in Antibody Drug Conjugates Market
Table 123. Recent Inorganic Growth Strategies in the Antibody Drug Conjugates Market
LIST OF FIGURES
Figure 1. Antibody Drug Conjugates Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Antibody Drug Conjugates Market Revenue (US$ Million), 2021-2031
Figure 5. Antibody Drug Conjugates Market Share (%) - by Technology (2023 and 2031)
Figure 6. Cleavable Linker: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Non-cleavable Linker: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Antibody Drug Conjugates Market Share (%) - by Application (2023 and 2031)
Figure 9. Blood Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Brain Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Breast Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Ovarian Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lung Cancer: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Antibody Drug Conjugates Market Share (%) - by Target (2023 and 2031)
Figure 16. HER2: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. CD22: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CD30: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Antibody Drug Conjugates Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 21. Retail Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Hospital Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Pharmacies: Antibody Drug Conjugates Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Antibody Drug Conjugates Market Breakdown by Region, 2023 and 2031 (%)
Figure 25. North America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. North America: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 27. North America: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 28. North America: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 29. North America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 30. North America: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. United States: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Canada: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Mexico: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 36. Europe: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 37. Europe: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 38. Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 39. Europe: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. United Kingdom: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Germany: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. France: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Spain: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 48. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 49. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 50. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 51. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. China: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Japan: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 54. India: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. Australia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 56. South Korea: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 57. Rest of APAC: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 60. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 61. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 62. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 63. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 64. South Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 65. Saudi Arabia: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 66. United Arab Emirates: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 67. Rest of Middle East and Africa: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 68. South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 69. South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 70. South and Central America: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 71. South and Central America: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 72. South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 73. South and Central America: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 74. Brazil: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 75. Argentina: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 76. Rest of South and Central America: Antibody Drug Conjugates Market - Revenue and Forecast to 2031(US$ Million)
Figure 77. Growth Strategies in Antibody Drug Conjugates Market
